SBRT for centrally localized NSCLC – What is too central?

Current guidelines recommend stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (NSCLC) in medically inoperable patients. There are excellent outcome and toxicity data for SBRT of per...

http://ift.tt/2fTjqaE